FOXP3 and systemic sclerosis: SSc patients showed increased frequency of CD3+CD4+CD25+Foxp3+ regulatory T lymphocytes (3.1% vs 0.6%, p<0.001), but, in this population, there was no difference in the percentage of cells expressing CD38 (40.2% vs 40%) (Figures 4A, B).